Keyphrases
Cluster Randomized Trial
100%
Adverse Drug Reaction
100%
Randomized Crossover
100%
Dutch Pharmacogenetics Working Group
100%
Pharmacogenetics Panel
100%
Clinically Significant
60%
Drug Treatment
60%
Drug-gene Interaction
60%
Odds Ratio
40%
Pharmacogenetic Testing
40%
Drug Therapy
40%
Interaction Test
40%
Genotype-guided
40%
Standard of Care
40%
One Dose
40%
Netherlands
20%
Treatment Duration
20%
Spain
20%
European Countries
20%
European Union
20%
Austria
20%
Italy
20%
Greece
20%
Genetic Testing
20%
Taking Part
20%
Community Pharmacy
20%
Slovenia
20%
Informed Consent
20%
Routine Care
20%
Clinical Utility
20%
Consecutive Days
20%
Genotyping Techniques
20%
Gatekeeping
20%
Health Systems
20%
Educational Materials
20%
Large-scale Implementation
20%
Exclusion Criteria
20%
Horizon 2020
20%
Guided Therapy
20%
Drug Combination
20%
Group Assignment
20%
Middle Eastern
20%
Patient Adherence
20%
Renal Insufficiency
20%
Lost to Follow-up
20%
Safety Analysis
20%
Community Health Centers
20%
Group Recommendation
20%
Preemptive Genotyping
20%
Germline Variants
20%
Actionable Variants
20%
Liver Insufficiency
20%
Gene Drug
20%
Local Team
20%
Medicine and Dentistry
Pharmacogenetics
100%
Adverse Drug Reaction
100%
Drug Therapy
55%
Gene Interaction
33%
Pharmacogenetic Testing
22%
Odds Ratio
22%
Health Care
11%
Community Pharmacy
11%
Informed Consent
11%
Clinician
11%
Treatment Duration
11%
Patient Referral
11%
Patient Compliance
11%
Severe Renal Impairment
11%
Community Health
11%
Genetic Screening
11%
Severe Hepatic Impairment
11%
Combination Drug
11%
Germ Cell
11%
Biochemistry, Genetics and Molecular Biology
Pharmacogenetics
100%
Drug Therapy
55%
Genotyping
33%
Gene Interaction
33%
Pharmacogenetic Testing
22%
Germline
11%
Genetic Screening
11%
Patient Compliance
11%
Germ Cell
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Adverse Drug Reaction
100%
Pharmacotherapy
45%
Community Pharmacy
9%
Severe Renal Impairment
9%
Severe Hepatic Impairment
9%
Combination Drug
9%